UBC Medical Indonesia Tbk. vs Lionmesh Prima Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume), while Lionmesh Prima Tbk. trades at Rp256 (market cap 24.58B). The key difference: UBC Medical Indonesia Tbk. is far larger — about 28.1× Lionmesh Prima Tbk.'s market cap. Which is the better fit depends on your goals.
| LABS | LMSH | |
|---|---|---|
Market Cap | 691.25B | 24.58B |
Volume | 635.5K | — |
Lot | 6.36K | — |
Turnover | 110.15M | — |
Average Price | 173.33 | — |
Value | 110.15M | — |
Indicative Equilibrium Price | 174 | — |
Indicative Equilibrium Volume | 50 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT Lionmesh Prima Tbk (the Company) was originally under the name PT Lion Weldmesh Prima and established on December 14, 1982. The Company its started commercial operations in 1984.
Read more on LMSH →